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Abstract
Background: Micronutrient inadequate intake is responsible of pathological deficiencies and there is a need of
assessing the effectiveness of metal supplementation, frequently proposed to rebalance poor diets. Manganese
(Mn) is present in many enzymatic intracellular systems crucial for the regulation of cell metabolism, and is
contained in commercially available metal supplements.
Methods: We compared the effects of two different commercial Mn forms, gluconate (MnGluc) and oxyprolinate
(MnOxP). For this purpose we used the polarized Caco-2 cells cultured on transwell filters, an established in vitro
model of intestinal epithelium. Since micronutrient deficiency may accelerate mitochondrial efficiency, the
mitochondrial response of these cells, in the presence of MnGluc and MnOxP, by microscopy methods and by ATP
luminescence assay was used.
Results: In the presence of both MnOxP and MnGluc a sustained mitochondrial activity was shown by mitoTraker
labeling (indicative of mitochondrial respiration), but ATP intracellular content remained comparable to untreated
cells only in the presence of MnOxP. In addition MnOxP transiently up-regulated the antioxidant enzyme Mn
superoxide dismutase more efficiently than MnGluc. Both metal treatments preserved NADH and bNADPH
diaphorase oxidative activity, avoided mitochondrial dysfunction, as assessed by the absence of a sustained
phosphoERK activation, and were able to maintain cell viability.
Conclusions: Collectively, our data indicate that MnOxP and MnGluc, and primarily the former, produce a
moderate and safe modification of Caco-2 cell metabolism, by activating positive enzymatic mechanisms, thus
could contribute to long-term maintenance of cell homeostasis.
Background
Inadequate dietary intake of micronutrients (i.e. essential
minerals, vitamins and other compounds, as mitochon-
drial metabolites) increases the risk of many degenera-
tive diseases [1]. Micronutrient deficiencies may
accelerate chronic metabolic disruption including mito-
chondrial decay, associated with aging diseases as can-
cer, heart disease, diabetes and neurodegenerative
processes [1]. Specific micronutrient restrictions seem to
be related to metabolic alterations affecting specific
functions. It is known that moderate to severe Zinc defi-
ciencies influence the immune functions in humans and
in animal models [2,3]. More recently, it has been
shown that Zinc exerts an important role in the
mechanisms of host defense in humans and Zinc sup-
plementation has been successfully used as a therapeutic
and preventive agent [4]. In addition, the contribution
of microminerals as Iron and Copper to the mainte-
nance of the balance between immunity and health in
humans has been demonstrated [5]. Noteworthy,
increasing the immunocompetence can decrease the risk
of inflammatory disorders, infectious diseases and can-
cer. However, the overload of micronutrient is toxic but
the early effects of these compounds on cell metabolism
are still poorly investigated. The use of micronutrient
supplementation in adults as part of short-term nutri-
tion therapy is acquiring importance in the metabolic
support of patients [6].
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Among the essential minerals present in the commer-
cially available nutritional and health supplements there
is Manganese (Mn). Mn is involved in enzymatic sys-
tems regulating the production of energy, protein meta-
bolism, bone formation, and synthesis of L-dopamine,
cholesterol and mucopolysaccharides. Divalent Mn may
function as antioxidant, by increasing the scavenging
activity of Mn-superoxide dismutase (MnSOD), the
principal antioxidant enzyme of mitochondria [7].
Indeed, Mn supplementation may help in the mainte-
nance of cell homeostasis, through the modulation of
mitochondrial bioenergetics, thus playing a protective
effect against acute inflammation, and likely contribut-
ing to pain reduction [8-10]. It has been demonstrated
that dietary inorganic nitrates enhance muscle mito-
chondrial efficiency, increasing the amount of ATP gen-
erated [8-10]. Mitochondrial failure and oxidative stress
have been postulated as major events in cell aging and
death [11]. Hence, the modulation of mitochondrial
activity through the assumption of antioxidant minerals
from food might help to reduce the risk of chronic dis-
eases of aging [12].
Following oral administration and before absorption,
epithelial cells of the small intestine represent the first
barrier encountered by Mn and other minerals. Previous
study demonstrates a net polarized transport across
intestinal epithelial cells for organic but not inorganic
Selenium salts, indicative of a different pathway for car-
bon containing respect to carbon non-containing com-
pounds [13]. More recently effect of bioactive dietary
poliphenols on zinc transport across the intestinal Caco-
2 cell monolayers has been studied [14]. Conversely,
despite the important role exerted by Mn compounds in
cell metabolism, the efficacy of Mn supplementation is
poorly studied. We hypothesized that Mn supplements
might influence the metabolism of intestinal epithelial
cells, possibly by increasing their mitochondrial activity.
To test our hypothesis, we used an established in vitro
model of polarized intestinal epithelium which mimics
the gut mucosa in vivo barrier [13,15,16], e.g. Caco-2
cells cultured in transwell. In this article we focused on
two commercially available organic Mn supplements,
Mn gluconate (MnGluc), and Mn Oxyprolinate
(MnOxP). The metal complexes of Gluconic acid are
highly absorbed by small intestine [17,18]. MnOxP,
which conjugate Mn to a proline analog, 5-oxyproline,
[19] as well as proline-rich peptides, have been proposed
to be useful intracellular delivery vectors [20]. Specific
objective of our study was to evidence the effects of
MnGluc and MnOxP on Caco-2 cell metabolism, in par-
ticular on mitochondrial function. Moreover, we have
compared the possible different activity of two
compounds.
Methods
Cells culture and monolayer quality control
Caco-2 cells were cultured on transwell polycarbonate
membranes in Dulbecco’s modified Eagle’s medium sup-
plemented with 10% fetal calf serum and nonessential
amino acids to acquire polarization and reach confluence
[15]. The electric resistance evaluated the cell continuity;
a transepithelial electric resistance ≥330 Ω/cm2 was
required to obtain a tight monolayer [21]. In all the
experiments the establishment of tight junctions [22] and
the development of apical brush border [23] were deter-
mined by confocal microscopy in two filters randomly
selected. These filters, upon fixation in 2% paraformalde-
hyde, were labeled with undiluted mouse-anti-human
Junctional Adhesion Molecule (JAM, clone BV16, kind
gift of Dr. Elisabetta Dejana, IFOM, The FIRC Institute
of Molecular Oncology Foundation, Milan) [24] or
mouse-anti-dipeptidyl-peptidase type IV (1:100, kind gift
of Dr. Ralph Witzgall Institute of Anatomy and Cell Biol-
ogy I, University of Heidelberg), both overnight at 4°C,
revealed by goat-anti-mouse IgG AlexaFluor-594 (1:500,
45 min, Molecular Probes, Eugene, OR). Following metal
supplementation studies, randomly chosen specimens
were frozen, crio-sectioned, and 10 mm thick transverse
sections were stained with Hematoxylin and Eosin to ver-
ify the morphology preservation at light microscope
(Eclipse 55i, Nikon, Tokyo, Japan).
Cell labeling for metal supplements study
Filters were divided in two parts. One half was stored
for enzymatic assays, the other labeled with mitoTraker
CMX-ROS (MT, 100 nM, 45 min, 37°C, Molecular
Probes, Eugene, OR) and with acridine orange (AO, 670
nM, 10 min, 37°C, Sigma-Aldrich, St. Louis, Missouri)
diluted in warm cell culture medium, to detect mito-
chondria oxidative activity [25] and cell viability [26],
respectively. After rinsing, fresh culture medium con-
taining MnOxP or MnGluc was added into transwell
upper chamber.
To obtain a reproducible response with a low standard
deviation, a dose-response was performed referring to
previous papers on Mn intracellular transport, using 7
μM, 12.5 μM and 25 μM of MnGluc or of MnOxP for
30 min, which contained Mn in quantities well tolerated
by Caco-2 cells [13,16].
Subsequently, time-course experiments were per-
formed, treating the polarized Caco-2 cells with 12.5
μM of the two metal compounds for < 5, 15, 30, 60, 120
min, and for 24 h. Experiments were threefold repeated.
Filters were fixed in 2% paraformaldehyde, rinsed in
PBS and mounted on glass slides for confocal analysis.
Several fixed filters, metal supplemented but unla-
beled, were doubly immunostained with Mouse-anti-
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phospho-ERK (pERK, diluted 1:250, 120 min; sc7383,
Santa Cruz Biotechnology, Santa Cruz, CA) and Rabbit-
anti-MnSOD (diluted 1:50, 4°C, overnight; Upstate Milli-
pore, Milan, Italy) revealed by Goat-anti-Mouse IgG
AlexaFluor594 and Donkey-anti-Rabbit AlexaFluor488
(both diluted 1:500, 45 min, Molecular Probes Invitro-
gen, Eugene, OR), respectively.
Untreated cells stained with AO/MT or with second-
ary antibodies only, and unstained monolayers excluded
the presence of fluorescent signals either due to metal
compounds or to autofluorescence.
Confocal microscopy
Filters were examined within 24 h from labeling by
Leica TCS SP (Leica Microsystems GmbH, Wetzlar Ger-
many) confocal microscope: Z-series were collected
from single channels, processed to obtain 2D free pro-
jection max (FPM) or cross-sectional images by Leica
Confocal Software, then merged by Adobe Photoshop
CS. Root Mean Square (RMS) of Fluorescence Intensity
was measured in at least three fields/filter at objective
x40 in AO/MT specimens.
ATP assay
ATP content was determined intracellularly and into
both apical and basal supernatants from Caco-2 cells
submitted to metal supplementation for 5 min, 30 min
and 24 h by bioluminescence-based assay (ATP Deter-
mination Kit, Molecular Probes, Eugene, OR). Speci-
mens were run in triplicate and the amount of ATP
calculated vs. a standard curve for a series of ATP
concentrations.
bNADPH-diaphorase and NADH-diaphorase
Histochemical assays for bNADPH-diaphorase and
NADH-diaphorase activities were performed as pre-
viously described [27,28] in 4 sets of half-filters, to
determine the contribution of nitric oxide synthase-
related oxidative activity and MnSOD immunoreactivity.
The presence of Blue Tetrazolium salts inside Caco-2
cells was evaluated under light microscope (Eclipse55i,
Nikon, Tokyo, Japan).
Statistical analysis
Statistical comparisons among the RMS data were per-
formed using the JMP4 statistical package (SAS Insti-
tute, Cary, NC) and Wilcoxon signed-ranks test.
Probability values p < 0.05 were considered significant.
Results
Intestinal epithelial cell model: quality control
Confluent monolayers of differentiated Caco-2 cells are
known as useful model to mimic intestinal epithelium,
when cultured on transwell under tightly controlled
conditions [15]. Confluency was tested by measuring
transepithelial electric resistance, and differentiation by
verifying the presence of tight junctions and brush bor-
der, stained with anti-JAM (Figure 1A) and anti-dipepti-
dyl-peptidase type IV (Figure 1B), respectively. Confocal
microscopy demonstrated a regular monolayer of cor-
rectly polarized cells with well-developed tight junctions
along the lateral and apical cell membrane contour, and
clear microvilli on the apical surface. Treatment of
Caco-2 cells with MnOxP and MnGluc did not alter the
monolayer and no sign of apoptosis was observed, as
revealed by Hematoxylin and Eosin stain (Figure 1C).
In all specimens, the AO (an indicator of cell viability)
brightly labeled the nuclei, without difference in respect
to nuclear condensation or chromatin fragmentation.
These findings indicated no increase in apoptotic events
and a good cell viability [26], thus supporting the mor-
phological findings (not shown). MnOxP and MnGluc
were undetectable inside the cells either under visible
light or fluorescence (not shown). Moreover, none of
the Caco-2 monolayers displayed fluorescence after
treatment with these compounds.
Confocal microscopy of Caco-2 cells submitted to metal
supplementation: mitochondrial activity
We hypothesized that treatment with metal supplements
is able to induce a fast and transient change in MT
kinetics. To set up the system, we compared the effects
of three different concentrations MnOxP or MnGluc
after 30 min incubation. Root mean square (RMS) fluor-
escence signals showed low standard deviation, indica-
tive of homogeneous intra-sample response, when Mn
compounds were used at concentration 12,5 μM (Figure
2): the same was employed in further experiments.
Two different series of experiments were performed
with MT: the first lasted up to 2 hours (brief) and the
others lasted 24 hours (long). Figure 3A displayed the
quantitative results obtained with MT. In brief experi-
ments, untreated Caco-2 cells showed elevated RMS for
MT fluorescence, indicative of active mitochondria.
Results obtained at 5 min and 30 min with and without
Mn supplementation were displayed. The reduction of
MT signal was significant at 5 min of both MnGluc (p
= 0.04) and MnOxP (p = 0.015) treatments respect to
untreated cells, possibly related to the compound entry
inside the cells. No significant differences were evi-
denced at 30 min. However, in long experiments, per-
formed by using cells treated either with MnGluc or
MnOxP for 24 hours, RMS of MT was slightly higher
than in untreated Caco-2 cells (p = 0.010 with both
compounds) (Figure 3A). No significant quantitative dif-
ference between MnGluc and MnOxP-treated Caco-2
monolayers was found for MT in any time of treatment.
Confocal microscopy displayed the qualitative
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distribution of MT signal at 30 min and overnight, con-
firming previous observations (Figure 3B). In addition,
mitochondria of Caco-2 cells treated with MnOxP over-
night resembled to those of untreated 30 min cells, pos-
sibly indicating a protective effect of MnOxP. Figure 3C
shows the distribution of labeled mitochondria by
MnOxP treated Caco-2 cells in brief experiments. At 15
min from the addition of MnOxP to Caco-2 cells MT
labeled mitochondria tended to localize close to the api-
cal surface, then (at 30 min, 1 hour and 2 hours) redis-
tributed into the cytoplasm. On the contrary, in
MnGluc-treated cells, no change in mitochondrial distri-
bution was observed (not shown).
ATP content
The intracellular content of ATP (Figure 4A) was signif-
icantly higher in control and MnOxP with respect to
MnGluc-treated Caco-2 cells (p < 0.05 for both) follow-
ing overnight treatment. In polarized cell monolayers
the ATP release is directed toward the apical extracellu-
lar space, thus ATP released by Caco-2 into the apical
supernatant (i.e. culture medium in the transwell upper
chamber) was one hundred fold less than intracellular
ATP (Figure 4B). During the first minutes of metal sup-
plementation, the monolayers treated with MnGluc
released apically around 2 fold more ATP than cells
incubated with MnOxP (p < 0.05). Successively (after 30
min and overnight treatments) ATP amount of all trea-
ted cells decreased to that of untreated cells (Figure 4B).
Low levels of ATP were detected in basal supernatants
of treated cells without significant differences with
untreated cells, except for slight (< 0.05) ATP decrease
Figure 2 Confocal microscopy of MT on polarized Caco-2
monolayers. Root Mean Square fluorescence intensity
quantification from dose-response experiment using cells incubated
with MnGluc or MnOxP is shown. Bars indicate standard deviation,
lowest at the intermediate concentration.
Figure 1 Microscopy characterization of the in vitro intestinal
epithelium model. Cross-sectional images from Caco-2 grown on
Transwell filters to form confluent monolayers of differentiated cell
are in panels A and B. A junction -rich, organized field is in panel A
(JAM white, DAPI blue). Another field with well-developed apical
brush border (DPPIV red) is in panel B. Inset in the bottom right
corner of panel B displays the 2D free projection max of the same.
In panel C Hematoxylin and Eosin stain shows a transversal
cryosection from a filter with cells treated with MnOxP for 30 min.
The morphology, i.e. columnar cells forming a tight and regular
monolayer, appears preserved.
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Figure 4 ATP measurement in Caco-2 cell treated with MnGluc
or MnOxP. Panel A shows the quantification of ATP in cell
homogenates. No difference between MnOxP -treated compared to
untreated cells was measured. Treatment with MnGluc diminished
the intracellular content of ATP at 24 h, respect to both MnOxP-
treated and untreated Caco-2 cells. ATP determination in apical
supernatants of Caco-2 cells in transwell system cell displays that
ATP release during the early times (5 min) of MnGluc
supplementation is significantly higher in comparison with both
MnOxP-supplemented and untreated cells (panel B). In the basal
supernatants the release of ATP is in nanomolar range, which
renders the statistical difference between MnGluc-treated and
untreated cells showed in the histogram not physiologically relevant
(panel C). Symbols: * indicates MnGluc differences (p < 0.05) respect
to MnOxP, # respect to untreated cells.
Figure 3 Confocal microscopy of polarized Caco-2 cells treated
with MnGluc or MnOxP- analysis of MT fluorescence.
Quantification and distribution of MT in response to 12.5 μM
MnGluc or MnOxP are shown. Root Mean Square fluorescence
intensity quantification from a representative long experiment is in
panel A. Symbols (o, #, *, §) indicate significant differences (p <
0.05) between Caco-2 cells responses. Panel B shows confocal MT
images from the same samples at 30 min and 24 h, in agreement
with data in panel A and displaying that the regular mitochondria
distribution is preserved in treated cells. Transversal 2D free
projection max (panel C) from a brief experiment displays both AO
and MT signals in the presence of MnOxP. MT shows a transient
redistribution of mitochondria close to the apex of cells at 15 min.
AO helps in localize the nuclei respect to MT and demonstrates the
cells viability.
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in overnight-treated MnGluc cells (Figure 4C), indicat-
ing that no abnormal ATP secretion is occurring in our
system.
Confocal microscopy of Caco-2 cells submitted to metal
supplementation: MnSOD/pERK
MnSOD was brightly expressed on the apical region of
untreated Caco-2, whereas pERK signal was faint. Con-
sequently, Figure 5A showed single cross-sectional plans
for double labeling MnSOD and pERK, and 2D FPM
images for pERK alone, with the aim to enhance infor-
mation. In the presence either of MnOxP or MnGluc,
few pERK granules were found into cytoplasm, mostly
at 5 min, and closely to MnSOD (Figure 5A). In treated
cells, pERK fluorescence decreased to a barely detectable
signal in 60 min of treatment (Figure 5A, right panels).
In the presence of both Mn compounds the signal for
MnSOD more homogenously localized in the apical part
of the cell cytoplasm respect to untreated cells as
demonstrated by x-z and y-z transversal projections
(Figure 5A, right panels). Caco-2 monolayers incubated
with MnGluc displayed a signal for MnSOD comparable
to that of untreated cells. In Caco-2 incubated with
MnOxP, MnSOD signal moderately increased at 15 min,
then decreased with time.
bNADPH-diaphorase and NADH-diaphorase
In mitochondrial diaphorase histochemistry, the punctu-
ate blue formazan stain differed for intensity depending
on the coenzyme used. The inhomogeneous signal (i.e.
its presence in all cells with irregular distribution and
intensity) hindered the reliability of a densitometry, lim-
iting to qualitative observation. bNADPH-diaphorase
(Figure 5B, left panels), indicative of nitric oxide
synthase activity, was weak; a modest increase was
observed at 15 and 30 min after MnOxP and at 30 min
after MnGluc, in comparison with untreated cells.
NADH-diaphorase (Figure 5B, right panels), i.e. MnSOD
reactivity, was higher in all treated monolayer than in
untreated, frequently showing cluster-restricted greatest
activity.
Discussion
Some minerals and vitamins have been reported as
micronutrients whose deficiencies might cause DNA
damage and accelerate mitochondrial decay associated
to degenerative diseases of aging [29] and cancer [1]. In
humans, the mineral absorption could be improved by
complexation with organic compounds such as gluco-
nate, as reported for Zinc [30]. However, controversial
results accounted for the bioavailability of these salts,
indicating a different behavior, which depends on target
cells or tissue and on pathological conditions. In anemic
cancer patients the intravenous supplementation with
Fe-gluconate increased the levels of blood hemoglobin
more than oral Iron therapy [31]. However, in healthy
female volunteers, orally administrated Zn-bis-glycinate
exhibited an higher Zinc bioavailability than Zn-gluco-
nate [32]. Moreover, in the rat liver Zn-enriched and
Cu-enriched yeasts were more bioavailable (i.e. absorbed
and found detected in a greater concentration) than Zn-
gluconate and Cu-gluconate [33]. Therefore, among ten
different organic and inorganic Magnesium salts orally
administered in Mg-depleted rats, Mg-gluconate exhib-
ited the highest Magnesium bioavailability at intestinal
level [34], slightly superior to Mg-pidolate and Mg-
citrate.
In the present work we study Mn, another essential
mineral that is a required component of a number of
mitochondrial enzymes including MnSOD, and whose
inadequate levels increase mitochondrial oxidants and
subsequent mitochondrial decay [7].
The following points resume the results obtained by
treating polarized Caco-2 cells with two different
organic Mn salts. 1) MnGluc and MnOxP does not
affect cell viability, as demonstrated by unaltered mor-
phology and by the transient raise of pERK expression.
2) In brief experiments, in the presence of MnOxP and
MnGluc, the mitochondrial activity is significantly lower
with respect to untreated cells at 5 min only. In long
experiments (24 h) both metal supplements moderately
improve the mitochondrial oxidative activity with
respect to untreated Caco-2 cells. 3) In comparison to
Caco-2 cells treated with MnOxP and untreated cells,
MnGluc-treated cells apically release a higher amount of
ATP at 5 min, and display a lower ATP intracellular
content at 24 h. 4) In treated cells MnSOD expression
is variable but sustained at all time points. 5) Both
bNADPH and NADH diaphorase activities are main-
tained by Caco-2 cells upon metal supplementation and
seem more sustained than in untreated cells at few time
points.
Taken together, in this in vitro model of intestinal
epithelium, our findings demonstrate that MnGluc
and MnOxP at the concentration of 12.5 μM are able
to elicit a rapid metabolic response, which relates to
mitochondrial activation. In metal supplemented
respect to untreated Caco-2 cells, the mitochondrial
oxidative activity is not significantly impaired, but
slightly increases after 24 h of treatment, as indicated
by MT fluorescence intensity. The limited changes in
mitochondrial oxidation, i.e. tendency of MT fluores-
cence to decrease during brief treatment, appear coun-
ter-balanced by MnSOD upregulation in both
MnOxP- and MnGluc-treated cells. MnSOD, an anti-
oxidant defense mitochondrial metalloenzyme, is con-
sidered a good parameter to monitorate Mn exposure
and protection in humans [35]. The increase in
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Figure 5 Confocal microscopyof pERK, MnSOD and diaphorase histochemistryon Caco-2 treated with MnGluc or MnOxP. Single plane
cross-sectional images of a z-series stack from Caco-2 cells doubly labeled for MnSOD (green) and pERK (red) are in panel A left. Cross sections
show x-y (squared), x-z and y-z (both rectangular) projections of the same field. Bright granular fluorescence for MnSOD with both metal
supplements is shown, but only faint granules of pERK are visible, indicative of mitochondria metabolically active and of healthy cells,
respectively. In panel A right the 2D free projection max obtained from all z-planes of the stack are shown, to evidence the contribution of
whole cells to pERK signal and to underline the scarce total expression of pERK. bNADPH- and NADH diaphorase assays (representative
experiment in panel B) demonstrates by the presence of stable blue formazan precipitate a prevalent activation of NADH- respect to bNADPH-
related enzymes upon incubation with MnGluc or MnOxP, a slightly different time-course with the two compounds and a moderate but non-
homogenous activation of NADH diaphorase in treated compared to untreated cells.
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MnSOD could scavenge superoxide anion, protecting
the cells from oxidative damage and apoptosis, and
ultimately self-regulating the oxidative stress [7]. Of
note, the mitochondrial activity appears higher in the
presence of both MnOxP and MnGluc than in
untreated cells, as shown by MT and by MnSOD.
In so far the MnSOD localization has been asso-
ciated to NADH-diaphorase reactivity on gut tissue
[28]. The untreated polarized Caco-2 confluent mono-
layers do not display elevate histochemical signal for
NADH- nor bNADPH-diaphorase, as previously
reported for DT-diaphorase [36]. Indeed, in MnOxP-
and MnGluc-treated cells NADH-diaphorase is highest
and increases with time, whereas bNADPH-diaphorase
weakly and transiently increases, suggesting a modest
activation of nitric oxide synthase [27]. Although we
cannot exclude a contribute of other enzymes of the
diaphorase family to enzymatic activity observed
in Caco-2 cells, the enhancement following Mn supple-
mentation supports the activation of a reductase-based
metabolism protective against oxygen radical
production.
The adverse effects of Mn supplementation depend on
the cell type (picomoles are toxic for astrocytes [37],
whereas micromoles are safe for enterocytes [13]) and
on the administration way [38]. In our model, a sus-
tained pERK activation, which is associated to abnormal
mitochondria [39] and to superoxide anion production
[40], is absent. This is demonstrated by the few more
pERK granules transiently appearing inside Caco-2 cyto-
plasm during the first 15 min of incubation either with
MnOxP or MnGluc, which revert within 60 min to the
level of untreated monolayers. A transient polarization
of mitochondria in MnOxP-treated monolayers accom-
panied the increase in pERK supportive of a mitochon-
dria response. Indeed, long experiments demonstrated a
general preservation of mitochondrial distribution in
Mn-supplemented Caco-2 cells with respect to
untreated cells. This observation excludes a commit-
ment to cell death via mitochondrial dysfunction, is in
agreement with morphological data, and supports the
hypothesis that metal supplements may not affect Caco-
2 cells viability, i.e. in these conditions MnGluc and
MnOxP are not toxic for enterocytes. However, our
findings are to be considered preliminary respect to the
effects of MnOxP and MnGluc on gut cells in vivo.
Although the general principles of nutrient risk assess-
ment have been established, the value of controlled
human studies on nutrient metabolism needs to be
improved [41]. In the nutritional field, despite the com-
mon use of supplements, the dietary quantity is crucial;
a safe and adequate daily dietary intake estimated 1.8-
2.3 mg Mn/day for adults [42]. High levels of Mn are
associated with neurodegenerative phenomena [38],
whereas low doses were claimed as beneficial in preven-
tion and treatment of osteoporosis in women [43].
Interestingly MnOxP does not deplete ATP content in
Caco-2 cell, whereas MnGluc decreases moderately ATP
levels in all the considered compartments. Together
with the moderate reduction of mitochondria oxidative
activity detected by MT, these findings suggest a
decreased production of ATP by still viable Caco-2 in
the presence of MnGluc, but an increased production in
the presence of MnOxP, less affecting cell healthiness.
These results support the hypothesis of a possible better
bioavailability in vivo for MnOxP than for MnGluc.
Conclusions
In summary, the treatment of polarized Caco-2 mono-
layers with MnOxP or MnGluc produces a moderate
and safe modification of cell metabolism, with the acti-
vation of positive enzymatic mechanisms, for a long-
term maintenance of cell homeostasis. This indicates a
good metabolic response to both supplements intake in
our in vitro model. However, between the two com-
pounds, MnOxP seems to act more rapidly and dissi-
pates less intracellular ATP. In conclusion, Mn
supplements and in particular MnOxP, could represent
a promising potential target to address pharmacological
studies aimed at prevention and treatment of degenera-
tive mitochondrial dysfunction and age-related diseases.
Further kinetics and in vivo investigations, carefully
designed to exclude harm, are required to confirm diet-
ary bioavailability of these compounds.
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